Safety and Efficacy of Meso-2,3-Dimercaptosuccinic Acid (DMSA) in Children with Elevated Blood Lead Concentrations
- 1 January 2000
- journal article
- clinical trial
- Published by Taylor & Francis in Journal of Toxicology: Clinical Toxicology
- Vol. 38 (4) , 365-375
- https://doi.org/10.1081/clt-100100945
Abstract
Objective: To evaluate the safety and efficacy of meso-2,3-dimercaptosuccinic acid in the treatment of children with lead toxicity. Design: This was an open-label study in 59 children 12–65-months ...Keywords
This publication has 21 references indexed in Scilit:
- Mobilization of heavy metals by newer, therapeutically useful chelating agentsToxicology, 1995
- Metabolism of meso-2,3-dimercaptosuccinic acid in lead-poisoned children and normal adults.Environmental Health Perspectives, 1995
- Childhood Lead Poisoning and its TreatmentAnnual Review of Pharmacology and Toxicology, 1993
- Herbal Medicine as a Cause of Combined Lead and Arsenic PoisoningHuman & Experimental Toxicology, 1990
- MESO-2,3-Dimercaptosuccinic Acid: Chemical, Pharmacological and Toxicological Properties of an Orally Effective Metal Chelating AgentAnnual Review of Pharmacology and Toxicology, 1990
- Developmental toxicity of subcutaneously administered meso-2,3-dimercaptosuccinic acid in miceFundamental and Applied Toxicology, 1988
- Dose-response study of oral 2,3-dimercaptosuccinic acid in children with elevated blood lead concentrationsThe Journal of Pediatrics, 1988
- 2,3-Dimercaptosuccinic acid as an antidote for lead intoxicationClinical Pharmacology & Therapeutics, 1985
- DMSA and DMPS-Water Soluble Antidotes for Heavy Metal PoisoningAnnual Review of Pharmacology and Toxicology, 1983
- Treatment of Schistosomiasis Mansoni with Antimony-a, a′-Dimercapto-Potassium Succinate (TWSb)The American Journal of Tropical Medicine and Hygiene, 1954